Anika Therapeutics
-
Recon
Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States
RevoMotion significantly expands Anika’s shoulder arthroplasty portfolio and provides a new solution in the over $800 million U.S. reverse shoulder…
Read More » -
Extremities
Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Expanding its Sports Medicine Soft Tissue Portfolio
X-Twist provides a simple, versatile knotless suture anchor system ideal for key repairs in the shoulder, foot and ankle, and…
Read More » -
Extremities
Anika Launches the WristMotion® Total Wrist Arthroplasty System at the American Society for Surgery of the Hand Annual Meeting
Designed to preserve natural motion and maximize stability, the WristMotion® Total Wrist Arthroplasty System provides an advanced solution for wrist…
Read More » -
Extremities
First Anika WristMotion® Total Wrist Arthroplasty Surgery Performed
WristMotion Total Wrist Arthroplasty limited launch initiated July 1, 2021 / Source: Anika Therapeutics Inc. BEDFORD, Mass., July 01, 2021 (GLOBE…
Read More » -
Financial
Anika Reports First Quarter 2021 Financial Results
Revenue lower by 3% versus pre-COVID in prior yearJoint Preservation revenue up 55% as transformative mix shift continuesCompany on track…
Read More » -
Extremities
Anika Announces FDA 510(k) Clearance for its WristMotion® Total Arthroplasty System for the Replacement of Painful Wrist Joints
BEDFORD, Mass., Oct. 21, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers…
Read More » -
Financial
Anika Appoints Michael Levitz as Chief Financial Officer
BEDFORD, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions…
Read More » -
Extremities
Anika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020
BEDFORD, Mass., July 20, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions…
Read More » -
Biologics
Anika Announces Planned CFO Transition
BEDFORD, Mass., June 02, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company…
Read More » -
Financial
Anika Reports First Quarter 2020 Financial Results
BEDFORD, Mass., May 07, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company,…
Read More » -
Biologics
Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer
April 27, 2020 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products…
Read More » -
Biologics
Anika Appoints David Colleran as General Counsel
March 04, 2020 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products…
Read More » -
Financial
Anika Therapeutics Closes Acquisition of Arthrosurface
BEDFORD, Mass., Feb. 03, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company…
Read More » -
Financial
Anika Therapeutics to Acquire Parcus Medical and Arthrosurface
January 06, 2020 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products…
Read More » -
Extremities
Anika Commences Full U.S. Commercial Launch of TACTOSET Bone Repair Therapy at Orthopaedic Summit 2019: Evolving Techniques
December 10, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products…
Read More »